Laddar...
Biomarkers of therapeutic response with immune checkpoint inhibitors
Immune checkpoint inhibitors (ICPIs) have revolutionized the treatment paradigm of a wide range of malignancies with durable responses seen in even advanced, refractory cancers. Unfortunately, only a small proportion of patients with cancer derive meaningful benefit to ICPI therapy, and its use is a...
Sparad:
| I publikationen: | Ann Transl Med |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
AME Publishing Company
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267267/ https://ncbi.nlm.nih.gov/pubmed/34277840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-6396 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|